Product Information
PHENOBARBITAL 15 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0766 per EA under NDC 00143149501. Its NADAC has been published 334 times since May 13, 2020.
Strength
15 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143149501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
3/5/2020
Price Statistics
The NADAC for PHENOBARBITAL 15 MG TABLET has been published 334 times since May 13, 2020, and over the history we have for it it has declined 62.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0766 per EA |
|---|---|
| All-time high | $0.2186 (Oct 12, 2022) |
| All-time low | $0.0614 (Apr 22, 2026) |
| 52-week high | $0.0823 |
| 52-week low | $0.0614 |
| Median price | $0.1142 |
| Average price | $0.1215 |
| Largest weekly change | +52.6% (May 17, 2023) |
| Weeks tracked | 334 |
| Tracking since | May 13, 2020 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phenobarbital market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 15 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0766 per EA (NDC 00143149501), effective Sep 30, 2026.
How has the price of PHENOBARBITAL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 15 MG TABLET has declined 62.4%. It has been tracked across 334 weekly CMS publications since May 13, 2020.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 15 MG TABLET?
Since May 13, 2020, the NADAC for PHENOBARBITAL 15 MG TABLET has ranged from a low of $0.0614 (Apr 22, 2026) to a high of $0.2186 (Oct 12, 2022), with a median of $0.1142 per EA.
Are there cheaper alternatives to PHENOBARBITAL 15 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHENOBARBITAL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PHENOBARBITAL 15 MG TABLET?
PHENOBARBITAL 15 MG TABLET (NDC 00143149501) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.